GLP1R and atherosclerosis: GLP-1 agonists exert a very important pleiotropic effect in improving cardiovascular health [21,22] and some of them, such as liraglutide, are able to improve subclinical atherosclerosis by reducing atherogenic small dense low-density lipoproteins (LDL) [23].